AURA
Price:
$8.95
Market Cap:
$443.97M
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2021-10-29
Stock Exchange
NASDAQ
Ticker
AURA
According to Aura Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 12.47. This represents a change of -30.47% compared to the average of 17.93 of the last 4 quarters.
The mean historical Current Ratio of Aura Biosciences, Inc. over the last ten years is 14.21. The current 12.47 Current Ratio has changed 8.67% with respect to the historical average. Over the past ten years (40 quarters), AURA's Current Ratio was at its highest in in the March 2021 quarter at 29.44. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
14.21
Median
18.76
Minimum
5.42
Maximum
21.14
Discovering the peaks and valleys of Aura Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 204.76%
Maximum Annual Current Ratio = 21.14
Minimum Annual Increase = -11.00%
Minimum Annual Current Ratio = 5.42
Year | Current Ratio | Change |
---|---|---|
2023 | 18.76 | -0.28% |
2022 | 18.81 | -11.00% |
2021 | 21.14 | 204.76% |
2020 | 6.94 | 27.87% |
The current Current Ratio of Aura Biosciences, Inc. (AURA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
19.57
5-year avg
14.21
10-year avg
14.21
Aura Biosciences, Inc.’s Current Ratio is greater than Aerovate Therapeutics, Inc. (8.78), greater than Adagene Inc. (2.50), less than Acrivon Therapeutics, Inc. Common Stock (12.75), less than Rezolute, Inc. (13.79), greater than AN2 Therapeutics, Inc. (9.75), less than Seer, Inc. (18.36), less than ORIC Pharmaceuticals, Inc. (13.15), greater than Anebulo Pharmaceuticals, Inc. (3.45), less than Cullinan Oncology, Inc. (24.46), greater than C4 Therapeutics, Inc. (6.31), less than Crinetics Pharmaceuticals, Inc. (16.38), greater than ALX Oncology Holdings Inc. (4.82), greater than Immatics N.V. (3.98), greater than BioAtla, Inc. (3.11), greater than Opthea Limited (2.94),
Company | Current Ratio | Market cap |
---|---|---|
8.78 | $76.81M | |
2.50 | $97.11M | |
12.75 | $202.87M | |
13.79 | $284.50M | |
9.75 | $39.99M | |
18.36 | $143.29M | |
13.15 | $676.74M | |
3.45 | $37.86M | |
24.46 | $730.17M | |
6.31 | $300.00M | |
16.38 | $5.20B | |
4.82 | $74.37M | |
3.98 | $905.91M | |
3.11 | $75.90M | |
2.94 | $486.27M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aura Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aura Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Aura Biosciences, Inc.'s Current Ratio?
How is the Current Ratio calculated for Aura Biosciences, Inc. (AURA)?
What is the highest Current Ratio for Aura Biosciences, Inc. (AURA)?
What is the 3-year average Current Ratio for Aura Biosciences, Inc. (AURA)?
What is the 5-year average Current Ratio for Aura Biosciences, Inc. (AURA)?
How does the current Current Ratio for Aura Biosciences, Inc. (AURA) compare to its historical average?